⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

Cavion (United States)

h-index: 3
Total citations: 183
Total papers: 14

Homepage: http://cavionpharma.com/

Recent papers from Cavion (United States)

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential Tremor: T-CALM Study Design and Methodology for Efficacy Endpoint and Digital Biomarker SelectionFrontiers in Neurology · 2019
Efficacy Result from a Phase 2, Double-Blind, Placebo-Controlled Study of CX-8998 a State-Dependent T-Type Calcium (Cav3) Channel Modulator in Essential Tremor Patients (T-CALM) (S4.008)Neurology · 2019
Targetable T-type Calcium Channels Drive GlioblastomaCancer Research · 2017
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to CarboplatinMolecular Cancer Therapeutics · 2016